Global Venous Ulcer Treatment Market to Reach USD 7.61 Billion by 2033 at a 6.5% of CAGR, Driven by Increasing Prevalence of Chronic Venous Diseases

Global Venous Ulcer Treatment Market

The global venous ulcer treatment market is anticipated to witness substantial growth over the next decade, driven by advancements in healthcare, increasing prevalence of chronic venous diseases, and rising awareness about wound care management. According to recent industry reports, the market is expected to be valued at USD 2.96 billion in 2023, with a projected compound annual growth rate (CAGR) of 6.5% from 2023 to 2033. By the end of this period, the global market is forecast to reach a valuation of USD 7.61 billion.

Venous ulcers, often caused by chronic venous insufficiency, represent a significant portion of chronic wounds globally. The rising geriatric population, along with an increasing number of individuals with underlying conditions such as diabetes and obesity, is expected to drive the demand for effective venous ulcer treatments.

Key Market Drivers:

• Technological Advancements in Wound Care: Innovations in treatment methods such as compression therapy, advanced dressings, and growth factor therapies are expected to enhance patient outcomes and accelerate market growth.
• Growing Healthcare Expenditure: Increasing government initiatives to improve healthcare infrastructure, particularly in emerging economies, is contributing to the expanding market for venous ulcer treatments.
• Rising Awareness and Accessibility: Awareness campaigns about the importance of early diagnosis and treatment of venous ulcers, along with improved access to advanced care, are fueling market expansion.

In 2022, North America led the global venous ulcer treatment industry. During the forecast years, it is expected to lead the market. During the forthcoming years, the European venous ulcer treatment market is expected to increase at an accelerating rate. The pervasive use of wound management additives across several growing economies, along with the United Kingdom, has developed significant revenue over the decades. North America dominated the worldwide market in 2022 and is predicted to continue to do so throughout the forthcoming years. The regional market is growing as more individuals use highly advanced wound care items and therapeutic interventions, particularly negative pressure wound treatment. In the near future, continuing R&D on these will expand new revenue opportunities.

Key Takeaways from the Market Study

• Demand increased significantly from 2018 to 2022, with a CAGR of 5.8%.
• According to a National Library of Medicine report, the overall prevalence of this disease is 1%, rising to 3% among those over 65.
• The prevalence of venous ulcers in the United States ranges from 1% to 3%. 2,3 According to the AAFP organization
• The global venous ulcer treatment market is estimated to be worth US$ 7.61 billion in 2033

Market Competition

Key players in the Venous Ulcer Treatment market are Angiodynamics, Sigvaris Global, Medi GmbH & Co. KG, Activa Healthcare, 3M, Medtronic, Bristol Myers Squibb Co, Sanofi, Bayer AG, Pfizer Inc, Novo Nordisk A/S. Some of the latest developments are

• The Sigvaris ULCER X Wound Healing Compression Stocking Kit, which was introduced in September 2020, is a simple and advanced solution for treating acute venous conditions and intense leg ulceration.
• Medi GmbH & Co. KG launched circaid® for venous leg ulcer as an adjustable compression device for the rehabilitation of venous leg ulcers in February 2020.

Key Companies Profiled

• Angiodynamics
• Sigvaris Global
• Medi GmbH & Co. KG
• Activa Healthcare
• 3M
• Medtronic Plc.
• Bristol Myers Squibb Co.
• Sanofi S.A
• Bayer AG
• Pfizer Inc.
• Novo Nordisk A/S

A Full Report Overview

Key Segments Profiled in the Venous Ulcer Treatment Market Industry Survey 

By Diseases Type:

• Arterial Ulcers
• Neurotropic Ulcer
• Venous Ulcers
• Diabetic Ulcers

By Treatment Type:

• Compression Therapy
• Surgical Therapy
• Skin Grafting
• Advanced Wound Dressing

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region:

• North America
• Europe
• South Asia
• East Asia
• Latin America
• Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube